LUCENTIS RANIBIZUMAB

Swiss trademark · 551295 · Combined mark · In force

Register entry

Registration number
551295
Application number
57676/2006
Status
In force
Type
Combined mark
As registered
LUCENTIS RANIBIZUMAB ((fig.))
Filed
Aug 28, 2006
Registered
Oct 19, 2006
Published
Nov 2, 2006
Protected until
Aug 28, 2036
Language of procedure
German
Vienna classes
26.07.25, 26.11.01, 26.11.09, 26.11.12, 27.05.01, 27.05.07
Source
Swissreg

Goods and services

Pharmaceuticals

Produits pharmaceutiques pour le traitement des maladies et troubles cardiovasculaires, des maladies et troubles oncologiques, des maladies et troubles immunitaires, des maladies et troubles de l'angiogénèse, des maladies et troubles oculaires ainsi que des maladies et troubles inflammatoires.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 8, 2026

    Renewed

    Expiry date
    28.08.2026 → 28.08.2036

    Published in Swissreg on 08.04.2026

  2. Feb 20, 2020

    Licensee entered

    Exclusive licensee
    Novartis Pharma AG, Lichtstrasse 35, 4002 Basel

    Published in Swissreg on 20.02.2020

  3. Apr 20, 2016

    Renewed

    Published in Swissreg on 20.04.2016

  4. Mar 10, 2011

    Agent entered

    Representative
    KATZAROV S.A., 19, Rue des Epinettes, 1227 Genève → F. Hoffmann-La Roche AG, Corporate Trademarks, 4002 Basel

    Published in Swissreg on 10.03.2011

  5. Dec 11, 2006

    Transferred

    Owner
    Genentech Espana, S.L., La Relba s/n, 36410 Porrino (Pontevedra), Spain → Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080-4918, USA
    Representative
    Katzarov SA, Rue des Epinettes 19, 1227 Genève → KATZAROV S.A., 19, Rue des Epinettes, 1227 Genève

    Published in the SOGC no. 240 of 11.12.2006

  6. Nov 2, 2006

    Registered

    Published in the SOGC no. 213 of 02.11.2006

Parties

Holder

GENENTECH, INC.

Genentech, Inc.

1 DNA Way, South San Francisco, CA 94080-4918, US

Agent

F. Hoffmann-La Roche AG

Corporate Trademarks, 4002 Basel

Exclusive licensee

Novartis Pharma AG

Lichtstrasse 35, 4002 Basel

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.